Pradaxa, Xarelto, Eliquis: NOACs’ Reversal a Key? http://www.medpagetoday.com/Cardiology/Prevention/45371?xid=nl_mpt_DHE_2014-04-23&utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=WC&eun=g578717d0r& From the article: Dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) — are touted for their safety, efficacy, and ease of use for both patient and physician, but these new oral anticoagulants (NOACs, pronounced No Ax) have one drawback in common: There is no antidote. Kowey said 6 […]
Filed under: General Problems | 2 Comments »